Credit: Christine Daniloff/MIT
A team of researchers from Brigham & Women’s Hospital, Mass. Institute of Technology and Mass. General Hospital demonstrated that localizing the delivery of NAMPT inhibitors can extend survival in a mouse model of glioma, according to a paper published this week in the Proceedings of the National Academy of Sciences.
The scientists created a test to check for a mutation linked to glioma and implanted microparticles that slowly elute drug over the course of several days or even weeks to treat the brain cancer.
Get the full story at our sister site, Drug Delivery Business News.
The post Researchers use microparticles for targeted delivery of brain cancer therapy appeared first on MassDevice.
from MassDevice https://ift.tt/2APTYhf
Cap comentari:
Publica un comentari a l'entrada